Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 25;75(6):564–572. doi: 10.1097/FJC.0000000000000827

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

FIGURE 3. — The pathological structure indicated by hematoxylin and eosin staining in control and different treatment groups (hematoxylin and eosin, ×200) (n = 3). A, Normal myocardial architecture of control group. (B) The DOX group showed vacuoles sarcoplasm, fragmentation, and degeneration of the myofibrillar, nuclei fade and detachment. (C) The latifolin (50 mg/kg) group showed mild degeneration of myocardial tissues; (D) the latifolin (100 mg/kg) group showed well-organized cardiac myofibers and nuclei profile.